Elimination of Tumorigenic Pluripotent Stem Cells from Their Differentiated Cell Therapy Products: An Important Step toward Ensuring Safe Cell Therapy

Investigators summarize current strategies to eliminate tumorigenic hPSCs, most of which target hPSC-specific markers, and critically evaluate the advantages and limitations of each approach.